Natco Pharma Shareholding Patterns
NSE: NATCOPHARM | BSE: 524816
₹805.05
As on 08-Nov-2026IST
Market cap
₹15,804 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13.8
P/B Ratio
1.5
Div. Yield
0.6 %
NSE: NATCOPHARM | BSE: 524816
₹805.05
As on 08-Nov-2026IST
Market cap
₹15,804 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13.8
P/B Ratio
1.5
Div. Yield
0.6 %
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month